Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, August 19, 2014

Ruxolitinib for myelofibrosis: Indication of considerable added benefit

Ruxolitinib has been approved since August 2012 for the treatment of adults with myelofibrosis.

http://ift.tt/1n66AxR

No comments:

Post a Comment

Popular Stem Cell Roundup Posts